Cannell & Spears’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.3M | Buy |
26,404
+176
| +0.7% | +$68.5K | 0.21% | 98 |
|
2025
Q1 | $11.4M | Sell |
26,228
-2,194
| -8% | -$954K | 0.25% | 91 |
|
2024
Q4 | $10.5M | Sell |
28,422
-37,810
| -57% | -$13.9M | 0.22% | 98 |
|
2024
Q3 | $34.4M | Sell |
66,232
-571
| -0.9% | -$297K | 0.68% | 51 |
|
2024
Q2 | $36.2M | Buy |
66,803
+121
| +0.2% | +$65.6K | 0.75% | 43 |
|
2024
Q1 | $34.6M | Buy |
66,682
+1,995
| +3% | +$1.03M | 0.71% | 45 |
|
2023
Q4 | $30.5M | Buy |
64,687
+182
| +0.3% | +$85.8K | 2.43% | 15 |
|
2023
Q3 | $28.1M | Buy |
64,505
+49
| +0.1% | +$21.3K | 2.41% | 16 |
|
2023
Q2 | $28.6M | Buy |
64,456
+59,858
| +1,302% | +$26.6M | 2.34% | 15 |
|
2023
Q1 | $2.11M | Buy |
+4,598
| New | +$2.11M | 0.19% | 60 |
|